Germany
Initial notification · 14.08.2026
Supply shortage: Renagel 800 mg Filmtabletten – OP 1x180
Affected country: Germany · Reported period: 10.08.2026 – 18.09.2026 · Active ingredient: Sevelamer
CountryGermany
PZN01587059
ENR2701414
Notification typeInitial notification
Start10.08.2026
Expected end18.09.2026
Last update14.08.2026
ReasonProduction problem
ATCV03AE02
Hospital-relevantYes
Notice context
A supply shortage has been recorded for Renagel 800 mg Filmtabletten – OP 1x180 in Germany. The stated reason is “Production problem”. The notice concerns the active ingredient Sevelamer and is identified as hospital-relevant.
This information describes the reported supply status and is not medical or pharmaceutical treatment advice. Availability, alternatives and further measures must be assessed for each individual case by the responsible pharmaceutical market participants.
Primary source: PharmNet.Bund / BfArM
Official shortage notice for Germany. Responsibility and update procedures follow the information supplied by the relevant authority.
Check the official notice list →